ARL6IP1 Use of ARL6IP1 for treatment of Hereditary Spastic Paraplegia

摘要

The present invention comprises a protein of ARL6IP1 (ADP ribosylation factor like GTPase 6 interacting protein 1) or a gene encoding the same as an active ingredient, the pharmaceutical composition for treatment of Hereditary Spastic Paraplegia (HSP) and the gene The present invention provides a method for screening a therapeutic agent for hereditary tonic paraplegia by measuring expression levels.